Inaktiver Wert

CB Scientific, Inc. Aktie Other OTC

Aktien

Dauer

Zeitraum

Stil

CB Scientific, Inc. FDA 510(k)-Einreichung des verbesserten myCam Cardiac Event Monitor bekannt gegeben	06.09.22	CI
CB Scientific, Inc. ernennt James Ott zum Chief Technology Officer	03.05.22	CI

CB Scientific, Inc. 2023 Year in Review	12.01.
CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor	06.09.22
CB Scientific : Entry into Material Definitive Agreement	23.08.22
CB Scientific : For the Period Ending June 30, 2022	12.08.22
CB Scientific : As of August 12, 2022	12.08.22

Manager	Titel	Alter	Seit
Charles Martin CEO	Chief Executive Officer	-	01.08.19
Brooke Martellaro DFI	Director of Finance/CFO	-	01.11.21
James Ott CTO	Chief Tech/Sci/R&D Officer	-	-

Aufsichtsräte	Titel	Alter	Seit
Paul Danner CHM	Chairman	64	01.10.21
Charles Martin CEO	Chief Executive Officer	-	01.08.19
Robert Kelley BRD	Director/Board Member	-	-

Sektor